|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��Ƥ����� |
|
̥�̸���� |
|
T-����� |
|
Ƥ���� |
| ��������������� | |
|
����ϼ |
|
Ϳ��ͥ |
| PubMed | |
|
Article by |
|
Article by |
�������ijЩƤ�������������е�����
����ϼ, Ϳ��ͥ
���пƼ���ѧͬ��ҽѧԺ����Э��ҽԺƤ���� �人 430030
�������ϸ����ϸ����𤸽����Ҫ�ɷ�,��Ƥ����֯���������ֻ���ά��������������Ҫ���á�Ŀǰ���о������������һЩƤ�����еı�Ｐ���Ծ����쳣������3�ָ������һЩƤ�����б���������ڷ������Ƶ�����,ΪƤ��������Ϻ������������˼·��
[2] Young P, Boussadia O, Halfter H, et al. E-cadherin controls adherens junctions in the epidermis and the renewal of hair follicles. EMBO J, 2003, 22:5723-5733.
[3] Zhou S, Matsuyoshi N, Liang SB, et al. Expression of T-cadherin in Basal keratinocytes of skin.J Invest Dermatol, 2002, 118:1080-1084.
[4] Hirai Y, Nose A, Kobayashi S, et al. Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis. Development, 1989, 105:271-277.
[5] Philippova M, Ivanov D, Tkachuk V, et al. Polarisation of T-cadherin to the leading edge of migrating vascular cells in vitro: a function in vascular cell motility? Histochem Cell Biol, 2003, 120:353-360.
[6] Huang ZY, Wu Y, Hedrick N,et al. T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol, 2003, 23:566-578.
[7] Papadavid E, Pignatelli M, Zakynthinos S, et al. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. J Pathol, 2002, 196:154-162.
[8] Wu H, Lotan R, Menter D, et al. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res, 2000, 20:1385-1390.
[9] Koseki S,Ansai S,Aoki T, et al. E-cadherin expression in skin tumors using an AMeX immunohistostaining method. J Dermatol, 2000, 27:307-311.
[10] Shirahama S, Furukawa F, Wakita H, et al. E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J Dermatol Sci, 1996, 13:30-36.
[11] Takeuchi T, Liang SB, Matsuyoshi N, et al. Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest, 2002, 82:1023-1029.
[12] Sanders DS, Blessing K, Hassan GA,et al. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol Pathol, 1999, 52:151-157.
[13] Zhou S, Matsuyoshi N, Takeuchi T,et al. Reciprocal altered expression of T-cadherin and P-cadherin in psoriasis vulgaris. Br J Dermatol, 2003, 149:268-273.